VistaGen Therapeutics, Inc. VTGN Cash Flow

Vistagen therapeutics, inc. (VTGN)

CashFlow / TTM

Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10
Cash flows from operating activities:
Net loss and comprehensive loss
-23,230	-24,485	-26,585	-24,589	-22,945	-18,733	-16,295	-14,345	-12,815	-12,449	-10,553	-10,255	-16,208	-15,716	-19,663	-47,220	-44,940	-43,883	-38,856	-13,885	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-10,911	-9,482	0	0	0
Net loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-2,967	-4,913	-10,379	-10,875	-12,886	0	0	0	-	-	-	-	-	-	-	-
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	53	55	55	54	53	47	40	33	33	36	40	45	46	46	46	45	0	0	0
Amortization of discounts on convertible and promissory notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	1,578	1,237	1,027	640	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Change in warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-247	-169	1,635	-357	0	0	77	30	-119	-115	-203	0	0	0
Change in warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Stock-based compensation
0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	807	1,121	1,142	1,137	1,173	1,517	1,368	1,241	1,105	760	1,222	1,591	1,854	1,793	1,660	1,628	0	0	0
Fair value of common stock granted for services
-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	-	134	134	134	0	0	156	313	340	792	635	478	452	0	0	0	-	-	-	-
Fair value of Series B Preferred stock granted for services
-	-	-	-	-	-	-	-	-	-	-	375	712	1,050	1,507	1,382	1,045	707	250	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of fair value of common stock issued for services
-	-	0	-	-	-	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-0	-0	-0	131	131	131	131	0	0	0	0
Amortization of fair value of warrants granted for services
-	-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Fair value of common stock issued for note term modification
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	22	22	22	22	0	0	0	-	-	-	-
Consulting services by related parties settled by issuing promissory notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0	0	0
Loss on disposition of equipment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0	0	0
Fair value of warrants granted for services and interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	45	44	54	60	87	181	187	183	714	613	583	564	0	0	0	-	-	-	-
Acquired in-process research and development
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0
Amortization of imputed discount on non-interest bearing notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0
Amortization of discounts on 7%, 7.5% and 10% notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	73	62	57	0	0	0	-	-	-	-
Amortization of discounts on 7%, 7.5% and 10% notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Amortization of discounts on Platinum notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	273	524	909	1,455	1,447	1,519	1,376	0	0	0
Amortization of discounts on August 2010 short-term notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	14	55	426	572	557	0	0	0
Amortization of discounts on February 2012 12% convertible notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	13	5	-4	0	0	0	-	-	-	-
Gain on currency fluctuation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-33	19	-53	0	0	0	-	-	-	-	-	-	-	-
Loss on currency fluctuation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Fair value of additional warrants granted pursuant to exercises of modified warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	35	174	174	172	138	0	0	0	-	-	-	-
Loss on settlements of accounts payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	78	0	0	0	-	-	-	-	-	-	-	-
Loss on extinguishment of debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	0	0	0	-	-	-	-	3,567	3,537	1,193	1,193	1,193	0	0	0	-	-	-	-
Non-cash rent and relocation expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Reversal of interest income on note receivable for stock purchase
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2	2	1	-1	-1	-1	-28	-30	-27	0	0	0	-	-	-	-	-	-	-	-
Changes in operating assets and liabilities:
Receivable from supplier
0	0	0	300	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Unbilled contract payments receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	106	7	127	148	-64	231	-77	-98	205	0	0	0
Prepaid expenses and other current assets
-610	5	-359	-589	93	-299	-178	-131	-53	-9	92	227	-65	-9	17	-25	-119	-31	-103	-107	110	37	116	92	118	75	13	46	-476	-116	181	-1	1,716	-374	-83	630	0	0	0
Right of use asset - operating lease
0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating lease liability
0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Security deposits and other assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-17	-17	-17	0	0	2	2	2	2	9	7	6	4	0	0	0
Accounts payable and accrued expenses
648	2,475	1,207	1,338	1,095	-137	1,186	541	-567	51	-658	-451	-208	-532	-1,105	-547	63	1,070	2,121	2,024	2,201	1,973	1,807	2,229	2,158	1,449	1,229	1,485	528	895	1,032	744	3,545	4,010	4,307	4,385	0	0	0
Expense related to modification of warrants, including exchange of warrants for common stock
-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	-	29	237	238	204	242	34	37	508	440	1,182	1,178	741	0	0	0	-	-	-	-
Deferred rent
-	-	-	-	-	-	-	-	-	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred rent
0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-13	-33	-13	-39	-65	-69	-195	-134	-60	0	0	0
Net cash used in operating activities
-16,735	-16,362	-16,153	-14,527	-13,573	-12,111	-10,059	-9,058	0	0	0	-	0	0	0	-	0	0	0	-	-2,341	-2,343	-2,406	-2,126	-2,628	-3,249	-3,898	-3,463	-3,211	-3,307	-2,775	-3,565	-2,937	-1,861	-1,602	-841	0	0	0
Construction of tenant improvements
0	0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchases of equipment
-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	-	-19	-43	-19	-9	276	169	145	135	-112	24	32	32	13	60	52	57	0	0	0
Net cash used in investing activities
-4	-4	-138	-174	-169	-169	-37	-1	-230	-233	-237	-239	-31	-34	-28	-26	0	0	0	-	19	43	19	9	-13	-169	-145	-135	-150	-24	-32	-32	-13	-60	-52	-57	0	0	0
Cash flows from financing activities:
Net proceeds from issuance of common stock and warrants, including Units
11,082	12,262	16,983	17,041	6,609	18,553	15,906	16,722	16,836	3,310	1,235	9,899	9,785	9,537	9,537	280	1,298	1,696	1,906	3,146	2,605	2,538	2,538	1,075	1,302	1,282	1,242	1,185	631	632	462	2,679	2,528	2,217	2,217	0	0	0	0
Net proceeds from issuance of Series B Preferred Units
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0
Net proceeds from issuance of Series B Preferred Units
-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net proceeds from issuance of Series B Preferred Units
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from exercise of modified warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	264	183	262	391	1,428	1,423	1,166	0	0	0	-	-	-	-
Proceeds from issuance of notes under line of credit
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0	0	0
Proceeds from issuance of 7% note payable to founding stockholder
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0	0	0
Proceeds from issuance of 7%note payable to founding stockholder
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0	0
Net proceeds from issuance of 7% convertible notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0	0	0
Net proceeds from issuance of 10% convertible notes and warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0	0	0
Net proceeds from issuance of preferred stock and warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	1,250	0	0	0	0	0	0	0	0	0
Net proceeds from issuance of 2008/2010 notes and warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	5	270	0	0	0
Net proceeds from issuance of notes and warrants from 2006 to 2010
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0	0	0
Proceeds from issuance of 7% notes payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0
Net proceeds from issuance of August 2010 short-term notes and warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	800	800	0	0	0
Net proceeds from issuance of February 2012 12% convertible notes and warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	466	466	466	466	0	0	0	-	-	-	-
Repayment of financing lease obligation
2	2	2	2	2	2	2	2	2	2	1	1	1	1	1	1	0	7	6	3	-9	-13	-7	-7	4	-4	-13	-16	23	-10	1	14	-17	28	27	27	0	0	0
Repayment of notes payable
272	250	228	220	214	209	204	203	195	168	143	182	166	167	168	111	152	159	211	303	266	251	294	148	4	-197	-532	-496	1,029	97	431	757	-610	617	495	205	0	0	0
Net cash provided by financing activities
11,517	12,607	17,358	17,423	6,997	18,348	15,699	16,516	0	0	0	-	0	0	0	-	0	0	0	-	2,334	2,312	2,716	1,497	2,639	3,411	4,101	4,155	3,219	3,251	1,897	3,539	2,838	1,571	2,499	837	0	0	0
Net decrease in cash and cash equivalents
-5,222	-3,759	1,065	2,722	-6,746	6,067	5,603	7,457	8,659	-4,492	-6,871	2,492	3,213	5,563	8,378	358	1,145	694	-279	70	-7	-6	310	-638	-3	-6	58	557	-142	-81	-910	-58	-113	-350	844	-61	0	0	0
Supplemental disclosure of noncash activites:
Conversion of Senior Secured Notes, Subordinate Convertible Notes, Promissory Notes, Accounts payable and other debt into Series B Preferred
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Insurance premiums settled by issuing note payable
0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued dividends on Series B Preferred
0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued dividends on Series B Preferred settled upon conversion by issuance of common stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Senior Secured Notes, 2014 Unit Notes, other promissory notes and related accrued interest, and accounts payable, including conversion premiums, converted into Series B Preferred stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-